MEOBF

AS OF

Dec 22 closing price

Price

$1.90

Change

+$0.55 (+40.74%)

Capitalization

2.49B

62 days until earnings call

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

MEOBF

Stock ticker: OTC

PRICE

CHANGE

CAPITALIZATION

Mesoblast (MEOBF) Earnings Date & Reports

Mesoblast Ltd is a commercial-stage biotechnology company and a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

MEOBF is expected to report earnings to 0 cents per share on February 26

Q4'25

Est.

$-0.01

Q3'25

Est.

$-0.01

Q2'25

Est.

$-0.04

Q4'24

Est.

$-0.01

Q3'24

Est.

$-0.01

The last earnings report on November 26 showed earnings per share of 0 cents, beating the estimate of 0 cents. With 1.00K shares outstanding, the current market capitalization sits at 2.49B.

View a ticker or compare two or three

Compare

MEOBF

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MEOBF showed earnings on November 26, 2025. You can read more about the earnings report here.

View AI-Driven Trading for MEOBF

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

Level 38, 55 Collins Street

Phone

+61 396396036

Employees

Web

https://www.mesoblast.com